Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study,The American Journal on Addictions

当前位置： X-MOL 学术 › The American Journal on Addictions › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study
The American Journal on Addictions ( IF 3.860 ) Pub Date : 2023-06-12 , DOI: 10.1111/ajad.13439
Hamzah Bakouni ₁ , Christina McAnulty _{1,

2} , Ovidiu Tatar _{1,

2} , M. Eugenia Socias _{3,

4} , Bernard Le Foll _{5,

6,

7,

8,

9} , Ron Lim ₁₀ , Keith Ahamad _{3,

11} , Didier Jutras‐Aswad _{1,

2} ,

Affiliation

Research Centre Centre Hospitalier de l'Université de Montréal (CRCHUM) Quebec Montréal Canada
Department of Psychiatry and Addictology Université de Montréal Québec Montréal Canada
British Columbia Centre on Substance Use Vancouver British Columbia Canada
Department of Medicine University of British Columbia, St. Paul's Hospital Vancouver British Columbia Canada
Department of Pharmacology and Toxicology, Faculty of Medicine, Medical Sciences Building University of Toronto Ontario Toronto Canada
Department of Family and Community Medicine, Faculty of Medicine University of Toronto Ontario Toronto Canada
Department of Psychiatry University of Toronto Ontario Toronto Canada
Dalla Lana School of Public Health University of Toronto Ontario Toronto Canada
Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute Center for Addiction and Mental Health (CAMH) Ontario Toronto Canada
Department of Family Medicine and Psychiatry, Cumming School of Medicine University of Calgary Calgary Alberta Canada
Department of Family Medicine, Faculty of Medicine University of British Columbia Vancouver British Columbia Canada

Buprenorphine/naloxone (BUP-NX) and methadone are used to treat opioid use disorder (OUD), yet there is insufficient evidence on the impact of doses on interventions' effectiveness and safety when treating OUD attributable to other opioids than heroin.

中文翻译：

美沙酮和丁丙诺啡纳洛酮剂量与处方型阿片类药物使用障碍中不受管制的阿片类药物使用、治疗保留和不良事件的关联：OPTIMA 研究的探索性分析

丁丙诺啡/纳洛酮 (BUP-NX) 和美沙酮用于治疗阿片类药物使用障碍 (OUD)，但在治疗海洛因以外的其他阿片类药物导致的 OUD 时，没有足够的证据表明剂量对干预措施的有效性和安全性的影响。

更新日期：2023-06-12

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文

全部期刊列表>>